Robert M Joseph1, Steven J Korzeniewski2,3, Elizabeth N Allred4,5, T Michael O'Shea6, Tim Heeren7, Jean A Frazier8, Janice Ware4,5, Deborah Hirtz9,10, Alan Leviton4,5, Karl Kuban9. 1. Department of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA. 2. Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, USA. 3. Department of Epidemiology & Biostatistics, Michigan State University, East Lansing, MI, USA. 4. Boston Children's Hospital, Boston, MA, USA. 5. Harvard Medical School, Boston, MA, USA. 6. Department of Pediatrics, University of North Carolina, Chapel Hill NC, USA. 7. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. 8. University of Massachusetts Memorial Health Care and University of Massachusetts Medical School, Worcester, MA, USA. 9. Department of Pediatrics, Boston Medical Center, Boston, MA, USA. 10. The University of Vermont Medical Center, Burlington, VT, USA.
Abstract
BACKGROUND: No prospective cohort study of high-risk children has used rigorous exposure assessment and optimal diagnostic procedures to examine the perinatal antecedents of autism spectrum disorder separately among those with and without cognitive impairment. OBJECTIVE: We sought to identify perinatal factors associated with increased risk for autism spectrum disorder with and without intellectual disability (intelligence quotient <70) in children born extremely preterm. STUDY DESIGN: This prospective multicenter (14 institutions in 5 states) birth cohort study included children born at 23-27 weeks' gestation in 2002 through 2004 who were evaluated for autism spectrum disorder and intellectual disability at age 10 years. Pregnancy information was obtained from medical records and by structured maternal interview. Cervical-vaginal "infection" refers to maternal report of bacterial infection (n = 4), bacterial vaginosis (n = 30), yeast infection (n = 62), mixed infection (n = 4), or other/unspecified infection (n = 43; eg, chlamydia, trichomonas, or herpes). We do not know the extent to which infection per se was confirmed by microbial colonization. We use the terms "fetal growth restriction" and "small for gestational age" interchangeably in light of the ongoing challenge to discern pathologically from constitutionally small newborns. Severe fetal growth restriction was defined as a birthweight Z-score for gestational age at delivery <-2 (ie, ≥2 SD below the median birthweight in a referent sample that excluded pregnancies delivered for preeclampsia or fetal indications). Participants were classified into 4 groups based on whether or not they met rigorous diagnostic criteria for autism spectrum disorder and intellectual disability (autism spectrum disorder+/intellectual disability-, autism spectrum disorder+/intellectual disability+, autism spectrum disorder-/intellectual disability+, and autism spectrum disorder-/intellectual disability-). Temporally ordered multinomial logistic regression models were used to examine the information conveyed by perinatal factors about increased risk for autism spectrum disorder and/or intellectual disability (autism spectrum disorder+/intellectual disability-, autism spectrum disorder+/intellectual disability+, and autism spectrum disorder-/intellectual disability+). RESULTS: In all, 889 of 966 (92%) children recruited were assessed at age 10 years, of whom 857 (96%) were assessed for autism spectrum disorder; of these, 840 (98%) children were assessed for intellectual disability. Autism spectrum disorder+/intellectual disability- was diagnosed in 3.2% (27/840), autism spectrum disorder+/intellectual disability+ in 3.8% (32/840), and autism spectrum disorder-/intellectual disability+ in 8.5% (71/840). Maternal report of presumed cervical-vaginal infection during pregnancy was associated with increased risk of autism spectrum disorder+/intellectual disability+ (odds ratio, 2.7; 95% confidence interval, 1.2-6.4). The lowest gestational age category (23-24 weeks) was associated with increased risk of autism spectrum disorder+/intellectual disability+ (odds ratio, 2.9; 95% confidence interval, 1.3-6.6) and autism spectrum disorder+/intellectual disability- (odds ratio, 4.4; 95% confidence interval, 1.7-11). Severe fetal growth restriction was strongly associated with increased risk for autism spectrum disorder+/intellectual disability- (odds ratio, 9.9; 95% confidence interval, 3.3-30), whereas peripartum maternal fever was uniquely associated with increased risk of autism spectrum disorder-/intellectual disability+ (odds ratio, 2.9; 95% confidence interval, 1.2-6.7). CONCLUSION: Our study confirms that low gestational age is associated with increased risk for autism spectrum disorder irrespective of intellectual ability, whereas severe fetal growth restriction is strongly associated with autism spectrum disorder without intellectual disability. Maternal report of cervical-vaginal infection is associated with increased risk of autism spectrum disorder with intellectual disability, and peripartum maternal fever is associated with increased risk for intellectual disability without autism spectrum disorder.
BACKGROUND: No prospective cohort study of high-risk children has used rigorous exposure assessment and optimal diagnostic procedures to examine the perinatal antecedents of autism spectrum disorder separately among those with and without cognitive impairment. OBJECTIVE: We sought to identify perinatal factors associated with increased risk for autism spectrum disorder with and without intellectual disability (intelligence quotient <70) in children born extremely preterm. STUDY DESIGN: This prospective multicenter (14 institutions in 5 states) birth cohort study included children born at 23-27 weeks' gestation in 2002 through 2004 who were evaluated for autism spectrum disorder and intellectual disability at age 10 years. Pregnancy information was obtained from medical records and by structured maternal interview. Cervical-vaginal "infection" refers to maternal report of bacterial infection (n = 4), bacterial vaginosis (n = 30), yeast infection (n = 62), mixed infection (n = 4), or other/unspecified infection (n = 43; eg, chlamydia, trichomonas, or herpes). We do not know the extent to which infection per se was confirmed by microbial colonization. We use the terms "fetal growth restriction" and "small for gestational age" interchangeably in light of the ongoing challenge to discern pathologically from constitutionally small newborns. Severe fetal growth restriction was defined as a birthweight Z-score for gestational age at delivery <-2 (ie, ≥2 SD below the median birthweight in a referent sample that excluded pregnancies delivered for preeclampsia or fetal indications). Participants were classified into 4 groups based on whether or not they met rigorous diagnostic criteria for autism spectrum disorder and intellectual disability (autism spectrum disorder+/intellectual disability-, autism spectrum disorder+/intellectual disability+, autism spectrum disorder-/intellectual disability+, and autism spectrum disorder-/intellectual disability-). Temporally ordered multinomial logistic regression models were used to examine the information conveyed by perinatal factors about increased risk for autism spectrum disorder and/or intellectual disability (autism spectrum disorder+/intellectual disability-, autism spectrum disorder+/intellectual disability+, and autism spectrum disorder-/intellectual disability+). RESULTS: In all, 889 of 966 (92%) children recruited were assessed at age 10 years, of whom 857 (96%) were assessed for autism spectrum disorder; of these, 840 (98%) children were assessed for intellectual disability. Autism spectrum disorder+/intellectual disability- was diagnosed in 3.2% (27/840), autism spectrum disorder+/intellectual disability+ in 3.8% (32/840), and autism spectrum disorder-/intellectual disability+ in 8.5% (71/840). Maternal report of presumed cervical-vaginal infection during pregnancy was associated with increased risk of autism spectrum disorder+/intellectual disability+ (odds ratio, 2.7; 95% confidence interval, 1.2-6.4). The lowest gestational age category (23-24 weeks) was associated with increased risk of autism spectrum disorder+/intellectual disability+ (odds ratio, 2.9; 95% confidence interval, 1.3-6.6) and autism spectrum disorder+/intellectual disability- (odds ratio, 4.4; 95% confidence interval, 1.7-11). Severe fetal growth restriction was strongly associated with increased risk for autism spectrum disorder+/intellectual disability- (odds ratio, 9.9; 95% confidence interval, 3.3-30), whereas peripartum maternal fever was uniquely associated with increased risk of autism spectrum disorder-/intellectual disability+ (odds ratio, 2.9; 95% confidence interval, 1.2-6.7). CONCLUSION: Our study confirms that low gestational age is associated with increased risk for autism spectrum disorder irrespective of intellectual ability, whereas severe fetal growth restriction is strongly associated with autism spectrum disorder without intellectual disability. Maternal report of cervical-vaginal infection is associated with increased risk of autism spectrum disorder with intellectual disability, and peripartum maternal fever is associated with increased risk for intellectual disability without autism spectrum disorder.
Authors: T Michael O'Shea; Bhavesh Shah; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; Olaf Dammann; Alan Leviton Journal: Brain Behav Immun Date: 2013-01-04 Impact factor: 7.217
Authors: Carolyn G DiGuiseppi; Julie L Daniels; Daniele M Fallin; Steven A Rosenberg; Laura A Schieve; Kathleen C Thomas; Gayle C Windham; Cynthia W Goss; Gnakub N Soke; Dustin W Currie; Alison B Singer; Li-Ching Lee; Pilar Bernal; Lisa A Croen; Lisa A Miller; Jennifer A Pinto-Martin; Lisa M Young; Diana E Schendel Journal: Disabil Health J Date: 2016-01-29 Impact factor: 4.615
Authors: Amanda T Langridge; Emma J Glasson; Natasha Nassar; Peter Jacoby; Craig Pennell; Ronald Hagan; Jenny Bourke; Helen Leonard; Fiona J Stanley Journal: PLoS One Date: 2013-01-07 Impact factor: 3.240
Authors: Sara L Hillman; Sarah Finer; Melissa C Smart; Chris Mathews; Robert Lowe; Vardhman K Rakyan; Graham A Hitman; David J Williams Journal: Epigenetics Date: 2015-01-23 Impact factor: 4.528
Authors: Rachel G Hirschberger; Karl C K Kuban; Thomas M O'Shea; Robert M Joseph; Tim Heeren; Laurie M Douglass; Carl E Stafstrom; Hernan Jara; Jean A Frazier; Deborah Hirtz; Julie V Rollins; Nigel Paneth Journal: Pediatr Neurol Date: 2017-11-13 Impact factor: 3.372
Authors: Barbara S E Verstraeten; J Keiko McCreary; Steven Weyers; Gerlinde A S Metz; David M Olson Journal: Biol Reprod Date: 2019-01-01 Impact factor: 4.285
Authors: Ann Kinga Malinowski; Cande V Ananth; Patrick Catalano; Erin P Hines; Russell S Kirby; Mark A Klebanoff; John J Mulvihill; Hyagriv Simhan; Carol M Hamilton; Tabitha P Hendershot; Michael J Phillips; Lisa A Kilpatrick; Deborah R Maiese; Erin M Ramos; Rosalind J Wright; Siobhan M Dolan Journal: Am J Obstet Gynecol Date: 2017-05-31 Impact factor: 8.661
Authors: Hassendrini N Peiris; Roberto Romero; Kanchan Vaswani; Sarah Reed; Nardhy Gomez-Lopez; Adi L Tarca; Dereje W Gudicha; Offer Erez; Eli Maymon; Murray D Mitchell Journal: J Matern Fetal Neonatal Med Date: 2019-12-29